250 filings
8-K
SONN
Sonnet BioTherapeutics Holdings Inc
11 Mar 24
Regulation FD Disclosure
7:30am
8-K
SONN
Sonnet BioTherapeutics Holdings Inc
6 Mar 24
Other Events
4:20pm
8-K
SONN
Sonnet BioTherapeutics Holdings Inc
14 Feb 24
Sonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update
7:35am
8-K
SONN
Sonnet BioTherapeutics Holdings Inc
1 Feb 24
Other Events
4:20pm
8-K
SONN
Sonnet BioTherapeutics Holdings Inc
29 Jan 24
Other Events
4:15pm
8-K
h2yio8uu4rx rti
27 Dec 23
Departure of Directors or Certain Officers
4:56pm
8-K
6ezty7
15 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
n5ztbr6shaa
14 Dec 23
Sonnet BioTherapeutics Provides Fiscal Year 2023 Business and Financial Update
5:03pm
8-K
x615 bdr0zy1aygjoi
19 Sep 23
Other Events
8:30am
8-K
y43sqm
1 Sep 23
Material Modifications to Rights of Security Holders
8:30am
8-K
z1bbgawucnlfqut
31 Aug 23
Sonnet BioTherapeutics Announces 1-for-22 Reverse Stock Split
5:18pm
8-K
n77d 599s0zcibvty
22 Aug 23
Other Events
8:30am
8-K
v8jx5 7wo
14 Aug 23
Sonnet BioTherapeutics Provides Fiscal Year 2023 Third Quarter Business and Earnings Update
8:15am
8-K
marpa8vxa vha8
20 Jul 23
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
7:31pm
8-K
kh86l3
30 Jun 23
Sonnet BioTherapeutics Announces $2.25 Million Registered Direct Offering and Concurrent Private Placement
8:59am
8-K
z2aq1 f4p
10 May 23
Sonnet BioTherapeutics Provides Fiscal Year 2023 Second Quarter and Year-to-Date Business and Earnings Update
7:30am
8-K
gr9avmzn3 t39
18 Apr 23
Sonnet BioTherapeutics Announces Updated Clinical Data for SON-1010 at the 2023 American Association for Cancer Research (AACR) Annual Meeting
5:00pm
8-K
439u5whx0b1y3c
24 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
lx1ymd
10 Mar 23
Regulation FD Disclosure
4:24pm
8-K
2j18d uip8vj
13 Feb 23
Sonnet BioTherapeutics Provides Fiscal Year 2023 First Quarter Business and Earnings Update
8:00am